Genesee & Wyoming Inc. (GWR) added that its traffic in May 2014 was 171,391 carloads, an amplifie of 3,864 carloads, or 2.3%, evaluated with May 2013. North American traffic mushroomed 6,133 carloads, or 4.2%, primarily due to swung overhead Class 1 shipments, coal, agricultural products and metals traffic. Coal & coke traffic prospered 1,886 carloads, or 6.7%, primarily due to grew steam coal shipments in G&W’s Midwest and Ohio Valley regions. The company’s traffic in the second quarter of 2014 through May was 341,904 carloads, an increase of 16,682 carloads, or 5.1%, measured up with the second quarter of 2013 through May. Genesee & Wyoming Inc. (NYSE:GWR), Railroads, is currently trading at $104.65, which boosted 1.73%. The stock is trading 1.42% below its 52-week high and 28.06% above its 52-week low. In valuation, Genesee & Wyoming Inc. maintained 2.62x price to book and 3.58x price to sales ratio. Company also recorded 0.72x debt over equity financial leverage. GWR showed 2.10% weekly performance. Analysts rate it a ‘Buy’ stock.
Northwestern Corp. (NWE) will hold its annual stockholders meeting on April 24, 2014, at 12:00 PM ET at the NorthWestern Energy Montana Operational Support Office, 40 East Broadway, Butte, Montana.
To access the live webcast, log on at www.northwesternenergy.com The price of Northwestern Corp. (NYSE:NWE), Diversified Utilities company, stock fostered 1.93% to $50.30. The stock is dealing at 1.45% below its 52-week high and 36.69% above its 52-week low. In valuation, Northwestern Corp. maintained 1.82x price to book and 1.61x price to sales ratio. Company also recorded 1.18x debt over equity financial leverage. NWE showed 4.79% weekly performance. We recommend to ‘Buy’ the stock.
OraSure Technologies (OSUR) declared Wednesday that it has stroked a Master Program Services and Co-Promotion Agreement with AbbVie (ABBV) under which AbbVie and OraSure will co-promote the Company’s OraQuick HCV Rapid Test in the United States. The product will be used to test individuals at-risk for hepatitis C (HCV). OraSure will be responsible for manufacturing and selling the product directly into all markets. As per the agreement, OraSure has granted exclusive promotion rights to AbbVie for the OraQuick HCV test in certain markets and will equip certain extra services in support of HCV testing. OraSure Technologies Inc. (NASDAQ:OSUR), Medical Instruments & Supplies company, swung 1.98% in last regular trading to $8.76. The stock is priced with the difference of 33.70% 200-day simple moving average and 31.58% 50-day moving average. OSUR has $489.25 million market capitalization. The stock recorded a trading volume of 750900 shares as compared to its average volume of 609.83 million shares. OSUR’s year to date performance is 39.27%. Experts rate it a ‘Buy’ stock.
Viper Energy Partners LP, a subsidiary of Diamondback Energy, Inc. (FANG) , and Diamondback declared the pricing of Viper’s initial public offering of 5 million common units at $26.00 per common unit, which is well above the cherished range of $19.00 to $21.00 per share. The company expects to close the offering on June 23, 2014. The Midland, Texas-based company’s common units are promising to begin trading on the NASDAQ Global Select Market on June 18 under the ticker symbol “VNOM.” In addition, Viper has granted underwriters a 30-day option to amalgamate more 750,000 common units at the initial public offering price. Upon consummation of offering, the public will own common units representing an roughly 7% limited partner interest in Viper (or an more or less 8% limited partner interest if the underwriters exercise in full their option to annex more common units). Diamondback will own remaining approximate 93% limited partner interest in Viper (or an approximate 92% limited partner interest if the underwriters exercise in full their option to pick up extra common units) and the general partner of Viper. Viper, which was formed in September 2013, intends to distribute offering net proceeds to Diamondback. Diamondback Energy, Inc. (NASDAQ:FANG), Independent Oil & Gas company, burgeoned 0.09% in last regular trading to $90.34. The stock is priced with the difference of 55.78% 200-day simple moving average and 21.51% 50-day moving average. The RSI of stock currently approaches at the level of 82.26 with 3.97% weekly volatility. The firm maintained its $1.60 EPS for the stock. FANG showed 98.59% half yearly performance. Experts rate it a ‘Buy’ stock.